Bio-Inspired Two-Phase Total Synthesis of Daphnepapytone A

14 March 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Daphnepapytone A (1) is an unprecedented guaiane-derived sesquiterpene characterized by a bridged and highly substituted cyclobutane. We describe its total synthesis through a bio-inspired, two-phase sequence of skeleton construction and late-stage oxidation. After the Eschenmoser-Tanabe fragmentation of (R)-carvone epoxide, the allenylation of the resulting aldehyde was followed by an allenic Pauson-Khand reaction with distal regioselectivity in presence of [Rh(CO)2Cl]2 to give the guaiane skeleton. Oleodaphnone (3) was identified as a key intermediate of this strategy and was engaged in a biomimetic [2+2]-photocycloaddition, leading to the bridged cyclobutane of the title compound. Finaly, a late-stage C-H oxidation chemoselectively released a triketone intermediate (15), which was reduced in a spectacularly chemo- and stereoselective manner to furnish target compound 1. During this work, complex rearrangements of the bridged skeleton were observed. Beside the first total synthesis of daphnepapytone A, this paper also describes the total synthesis of three guaiane natural products (oleodaphnone, diarthroncha C, daphnenicillata W), one of them being structurally revised.

Keywords

bridged products
[2+2] cycloaddition
rearrangements
late-stage oxidation
total synthesis

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
Supplementary figures and tables Experimental procedures Computational details X-ray crystallography details Copies of NMR and HRMS spectra Further references
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.